Spravato® is a medication primarily used for treatment resistant depression. It is inhaled through the nose using a device similar to nasal sprays such as saline and Flonase. Spravato® may also be used for acute suicidal ideation. Spravato® must be administered at a certified facility with a licensed healthcare professional on site.

Spravato® is not for everyone. Patients must have a formal diagnosis of major depressive disorder, which is not is remission despite the use of at least 2 medications for depression. Treatment for depression, including at least one medication, must continue during the course of treatment with Spravato®. Certain medications may not be used in conjunction with Spravato®. Patients must be evaluated by our mental health professional(s) to see if Spravato® is right for you.

Important points to consider before your consultation:

• • Treatment sessions are a minimum of 120 minutes (2 hours) each
  • Patients must remain on site for the duration of treatment
  • Patients cannot drive to or from treatment, nor for the remainder of the day following treatment
  • Time commitment for treatment
    • Weeks 1-4: twice weekly, 48 hours apart
    • Weeks 5-9: once weekly
    • After week 9: once weekly or once every other week
      • Depending upon the recommendation from your healthcare provider
  • Treatment may persist for as long as needed
  • Uncontrolled blood pressure may exclude patients from Spravato®

To see if Spravato® is right for you, please call or text our office to schedule your discovery visit: 757-659-9903. We look forward to working with you to prioritize your mental health.